Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives

News

 17th June 2011 The Controlled Release Society (CRS)

Delivery Science Experts Present Research in National Harbor, Maryland, U.S.A.

ST. PAUL (June 17, 2011) – Delivery science and technology experts from more than 50 countries will gather July 30–August 3, 2011 during the 38th Annual Meeting & Exposition of the Controlled Release Society at the Gaylord National Hotel and Convention Center in National Harbor, Maryland, U.S.A. The Controlled Release Society (CRS), an international, multidisciplinary society dedicated to the science and technology of delivery, provides the annual meeting as an opportunity to dissect and discuss a variety of topics that have affected healthcare and consumer products throughout the year.

The 2011 CRS Annual Meeting & Exposition features an outstanding program with industry leaders presenting on such topics as consumer and diversified products, biological research tools, cancer therapeutics, quality design and pediatric drug development, and much more. In addition, more than 650 technical posters and 200 oral technical presentations are available. Attendees will have the opportunity to participate in scientific and technical sessions, present research results, attend special events, learn about new products and services, and connect with others who share their interests. Attendees will come from academia, government, industry, and private practice.

This year’s plenary speakers include:

*Gordon Amidon, Professor of Pharmacy, University of Michigan U.S.A., Optimal Oral Delivery: From Empiricism to Mechanism *Henry Brem, Chair of Neurosurgery, John Hopkins Hospital, U.S.A., Challenges of Therapeutic Delivery to the Brain *Adam Heller, Abbott Diabetes Care, U.S.A., Focusing on the Need of the Patient in Medical Innovation *Gordon Muirhead, Vice President and Dose Form Leader SDF, GlaxoSmithKline, United Kingdom, Continuous Processing: Powder In, Tablets Out *Walter Orenstein, Deputy Director for Vaccine-Preventable Diseases, Gates Foundation U.S.A., Critical Factors in the Making of Immunization Policy Members of the media will receive complimentary registration to the Annual Meeting & Exposition.


 

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |